Collegium Pharmaceutical, Inc.

September 29, 2016

Counsel to Collegium Pharmaceutical, Inc. in a series of related cases involving six patents owned by Purdue and related entities related to oxycodone. Obtained a judgment of invalidity of the three Orange Book listed patents in Purdue Pharma LP v. Collegium Pharm. after succeeding in a motion to transfer the action from the District of Delaware to the District of Massachusetts

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Back to Top